Press

If you would like to discuss anything press related, please email rarecan@ovidhealth.co.uk

RareCan in the News

National Health Executive – 24 January 2022 – Digitalisation of Clinical Trials

Novopath – 9 December 2021 – Novopath & RareCan Research and Innovation Collaboration 

Newcastle Chronicle – 25 November –  Inside the Newcastle ‘BioBank’ of blood and tissue samples which could help cure rare cancers

Drug Discovery World – 23 November – Accelerating Research:  The Path Forward for Treating Rare Cancers

Adlib Recruitment – 19th November –  Product People Potential – Our Chat with RareCan Limited

weareumi – 10th November – Go Further Investment Index Celebrates most Progressive Northern UK Businesses 

EPM Magazine – 9th November – Blood Cancer UK Partners with RareCan to Improve Delivery of Clinical Trials

Technology Networks – 9th November – RareCan Receives Approval from NHS Research Ethics Committee to Establish Vital BioResource at Newcastle University

Northern Echo – 4th November – Teesside University New Cancer Treatment Research Partnership

PharmaTimes – 2nd November 2021  – Putting Digitally Empowered Patients at the Core of Rare Cancer Research

Drug Discovery World – 26th October 2021 – RareCan Receives approval to establish BioResource at Newcastle University

Newcastle Chronicle – 5th October 2021 – Newcastle professor’s ‘matchmaking’ site helps patients with rare cancers find the clinical trials that could save their lives 

Pharmafile – 25th August 2021  – RareCan appoints Dr Anita Cooper

Drug Discovery World – 4th August 2021 – Appointment strenghtens the experience of RareCanG